This activity reviews the incidence and impact of opioid-induced constipation (OIC), discusses available treatment options, and what factors should be considered during formulary decisions for OIC.
Kenneth C. Jackson II, PharmD, CPE
Advertisement
Articles by Kenneth C. Jackson II, PharmD, CPE
Advertisement
Latest Updated Articles
- Opioid-Induced Constipation: Considerations for Formulary Decision Makers
Published: June 19th 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Is Berberine Nature’s GLP-1?
2
Experts Highlight Key Sessions and Emerging Topics from The Menopause Society 2025 Annual Meeting
3
Ban Synthetic 7-OH: Natural Leaf Kratom Presents No Major Health Risk
4
Incidence of VAIs in Patients With Chronic Kidney Disease on Dialysis Relatively Low
5
